semaglutide 2.4 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial Wegovy 2.4 mg/0.75 mL pre-filled
Description
Don't use it

Instead, mRNA expression is detected in myenteric ganglia in the intestinal mucosa, which are excitable by GLP-1 treatment ex vivo (64% synaptic and 36% after-hyperpolarizing types) (Figure 1 and Table 2)

Products for research only

This proved GLP-1 was a powerful antidiabetic agent

Does everyone on Ozempic get sulfur burps

What you really need to know : stronger weight loss in trials doesnt mean everyone should rush in- screening , medical supervision, and long-term plan matter